🔎 Trials Near Me

Beranda › Penyakit Crohn › Missouri › St. Louis

Uji klinis Penyakit Crohn di St. Louis, MO

19 studi untuk Penyakit Crohn mencari peserta di lokasi sekitar St. Louis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Menerima pesertaFase 2
  • Specialists In Gastroenterology /ID# 283939, St Louis
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Menerima pesertaFase 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Menerima pesertaFase 3
  • Washington University School of Medicine ( Site 5058), St Louis
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Menerima pesertaFase 4
  • SSM Health Medical Group, Bridgeton · 15 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Menerima pesertaFase 2
  • Washington University /ID# 266938, St Louis
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Menerima pesertaFase 3
  • Washington University School of Medicine, St Louis
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • Washington University School of Medicine-Site Number: 8400075, St Louis
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Menerima pesertaFase 3
  • Washington University School of Medicine, St Louis
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Menerima pesertaFase 2
  • KAD Clinical Research, St Louis
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 2
  • SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mi jauhnya
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Menerima pesertaFase 2
  • KAD Clinical Research, St Louis
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Menerima pesertaFase 4
  • Washington University School of Medicine, St Louis
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06045754

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

Menerima pesertaFase 2
  • Washington University, St. Louis, St Louis
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Menerima pesertaFase 2
  • Washington University School of Medicine, St Louis
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT06976853

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Menerima pesertaFase 2
  • Investigational Site Number: 8400013, St Louis
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Menerima pesertaFase 2
  • Mirador Therapeutics Selected Site, Bridgeton · 15 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

Menerima pesertaFase 1/2
  • Washington University in St. Louis, St Louis
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 10 Des 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Menerima pesertaStudi observasional
  • Washington University in St Louis School of Medicine, St Louis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Nov 2025 · NCT06670638

Uji klinis Penyakit Crohn di kota lain

Studi lain di St. Louis

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.